Bioinformatics, Computational Chemistry and Science

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioinformatics

Computational Chemistry

Science

AI in Drug Discovery - A Highly Opinionated Literature Review (Part III)

Practical Cheminformatics

JANUARY 16, 2024

Following up on Part I and Part II, the third post in this series is a collection of review articles published in 2023 that I found helpful.

Targeted Protein Degradation

Targeted Protein Degradation Small Molecule Computational Chemistry Bioinformatics

Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases

The Pharma Data

NOVEMBER 15, 2020

Our rigorous target selection process, translational screening cascade, and smart medicinal chemistry have been essential to bring this project to this stage. Lead Pharma is headquartered at Pivot Park, the biopharmaceutical life sciences campus in Oss, the Netherlands. ” About Immune Mediated Diseases.

Small Molecule

Small Molecule Licensing Licensing Disease

Reaching cruising altitude: New discovery tools to target RNA

Dark Matter Blog

AUGUST 31, 2020

Emblematic of Arrakis’ collaborative approach to science, almost all of the scientists in the lab—or, in the case of our colleagues in computational chemistry and biology, on their computers—at the time contributed to developing the PEARL-seq platform. With any luck, we’ll figure out our landing gear next.

RNA

RNA Small Molecule Bioinformatics Computational Chemistry

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Drug Discovery Digest

AI in Drug Discovery - A Highly Opinionated Literature Review (Part III)

Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases

Reaching cruising altitude: New discovery tools to target RNA

Webinars

Stay Connected